Nature Medicine
2026-06-19 00:00
DOI:
HASH:bb6ce0b2117600d648b897139754f490
Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
作者:
摘要 / Abstract
该条目无摘要（多为勘误、社论或新闻类内容，出版方未提供摘要）